{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:36:18Z","timestamp":1792571778910,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,1,16]],"date-time":"2009-01-16T00:00:00Z","timestamp":1232064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s00125-008-1255-x","type":"journal-article","created":{"date-parts":[[2009,1,15]],"date-time":"2009-01-15T15:18:23Z","timestamp":1232032703000},"page":"626-635","source":"Crossref","is-referenced-by-count":206,"title":["Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis"],"prefix":"10.1007","volume":"52","author":[{"given":"S.","family":"Zraika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. L.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Udayasankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Aston-Mourney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. L.","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kisilevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. A.","family":"Szarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. E.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,16]]},"reference":[{"key":"1255_CR1","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","volume":"84","author":"P Westermark","year":"1987","unstructured":"Westermark P, Wernstedt C, Wilander E, Hayden DW, O\u2019Brien TD, Johnson KH (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84:3881\u20133885","journal-title":"Proc Natl Acad Sci USA"},{"key":"1255_CR2","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","volume":"84","author":"GJ Cooper","year":"1987","unstructured":"Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84:8628\u20138632","journal-title":"Proc Natl Acad Sci USA"},{"key":"1255_CR3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-5793(89)81467-X","volume":"251","author":"C Betsholtz","year":"1989","unstructured":"Betsholtz C, Christmansson L, Engstrom U et al (1989) Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species. FEBS Lett 251:261\u2013264","journal-title":"FEBS Lett"},{"key":"1255_CR4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0014-4827(89)90407-2","volume":"183","author":"C Betsholtz","year":"1989","unstructured":"Betsholtz C, Svensson V, Rorsman F et al (1989) Islet amyloid polypeptide (IAPP):cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus. Exp Cell Res 183:484\u2013493","journal-title":"Exp Cell Res"},{"key":"1255_CR5","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","volume":"87","author":"P Westermark","year":"1990","unstructured":"Westermark P, Engstrom U, Johnson KH, Westermark GT, Betsholtz C (1990) Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 87:5036\u20135040","journal-title":"Proc Natl Acad Sci USA"},{"key":"1255_CR6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.5.5.527","volume":"5","author":"E Opie","year":"1901","unstructured":"Opie E (1901) The relation of diabetes mellitus to lesions of the pancreas: hyaline degeneration of the islets of Langerhans. J Exp Med 5:527\u2013540","journal-title":"J Exp Med"},{"key":"1255_CR7","first-page":"47","volume":"1","author":"P Westermark","year":"1994","unstructured":"Westermark P (1994) Amyloid and polypeptide hormones: what is their relationship. Amyloid Int J Exp Clin Invest 1:47\u201360","journal-title":"Amyloid Int J Exp Clin Invest"},{"key":"1255_CR8","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","volume":"93","author":"CB Verchere","year":"1996","unstructured":"Verchere CB, D\u2019Alessio DA, Palmiter RD et al (1996) Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci USA 93:3492\u20133496","journal-title":"Proc Natl Acad Sci USA"},{"key":"1255_CR9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/diabetes.52.2.372","volume":"52","author":"RL Hull","year":"2003","unstructured":"Hull RL, Andrikopoulos S, Verchere CB et al (2003) Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes 52:372\u2013379","journal-title":"Diabetes"},{"key":"1255_CR10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bbrc.2006.12.187","volume":"354","author":"S Zraika","year":"2007","unstructured":"Zraika S, Hull RL, Udayasankar J et al (2007) Glucose- and time-dependence of islet amyloid formation in vitro. Biochem Biophys Res Commun 354:234\u2013239","journal-title":"Biochem Biophys Res Commun"},{"key":"1255_CR11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/368756a0","volume":"368","author":"A Lorenzo","year":"1994","unstructured":"Lorenzo A, Razzaboni B, Weir GC, Yankner BA (1994) Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368:756\u2013760","journal-title":"Nature"},{"key":"1255_CR12","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1074\/jbc.271.4.1988","volume":"271","author":"TA Mirzabekov","year":"1996","unstructured":"Mirzabekov TA, Lin MC, Kagan BL (1996) Pore formation by the cytotoxic islet amyloid peptide amylin. J Biol Chem 271:1988\u20131992","journal-title":"J Biol Chem"},{"key":"1255_CR13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","volume":"48","author":"J Janson","year":"1999","unstructured":"Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC (1999) The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48:491\u2013498","journal-title":"Diabetes"},{"key":"1255_CR14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/bj3430053","volume":"343","author":"JZ Bai","year":"1999","unstructured":"Bai JZ, Saafi EL, Zhang S, Cooper GJ (1999) Role of Ca2+ in apoptosis evoked by human amylin in pancreatic islet beta-cells. Biochem J 343:53\u201361","journal-title":"Biochem J"},{"key":"1255_CR15","doi-asserted-by":"crossref","first-page":"11338","DOI":"10.1021\/bi020314u","volume":"41","author":"M Anguiano","year":"2002","unstructured":"Anguiano M, Nowak RJ, Lansbury PT Jr (2002) Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. Biochemistry 41:11338\u201311343","journal-title":"Biochemistry"},{"key":"1255_CR16","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1073\/pnas.93.14.7283","volume":"93","author":"J Janson","year":"1996","unstructured":"Janson J, Soeller WC, Roche PC et al (1996) Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci USA 93:7283\u20137288","journal-title":"Proc Natl Acad Sci USA"},{"key":"1255_CR17","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1111\/j.1742-4658.2006.05367.x","volume":"273","author":"B Konarkowska","year":"2006","unstructured":"Konarkowska B, Aitken JF, Kistler J, Zhang S, Cooper GJ (2006) The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells. Febs J 273:3614\u20133624","journal-title":"Febs J"},{"key":"1255_CR18","doi-asserted-by":"crossref","first-page":"E1317","DOI":"10.1152\/ajpendo.00082.2006","volume":"291","author":"JJ Meier","year":"2006","unstructured":"Meier JJ, Kayed R, Lin CY et al (2006) Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. Am J Physiol Endocrinol Metab 291:E1317\u2013E1324","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1255_CR19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF01219652","volume":"15","author":"P Westermark","year":"1978","unstructured":"Westermark P, Wilander E (1978) The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 15:417\u2013421","journal-title":"Diabetologia"},{"key":"1255_CR20","first-page":"151","volume":"9","author":"A Clark","year":"1988","unstructured":"Clark A, Wells CA, Buley ID et al (1988) Islet amyloid, increased A-cells, reduced B cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 9:151\u2013159","journal-title":"Diabetes Res"},{"key":"1255_CR21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102\u2013110","journal-title":"Diabetes"},{"key":"1255_CR22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.freeradbiomed.2005.04.030","volume":"41","author":"RP Robertson","year":"2006","unstructured":"Robertson RP, Harmon JS (2006) Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet beta cell. Free Radic Biol Med 41:177\u2013184","journal-title":"Free Radic Biol Med"},{"key":"1255_CR23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s125-002-8248-z","volume":"45","author":"H Sakuraba","year":"2002","unstructured":"Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S (2002) Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia 45:85\u201396","journal-title":"Diabetologia"},{"key":"1255_CR24","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1111\/j.1742-4658.2005.04903.x","volume":"272","author":"B Konarkowska","year":"2005","unstructured":"Konarkowska B, Aitken JF, Kistler J, Zhang S, Cooper GJ (2005) Thiol reducing compounds prevent human amylin-evoked cytotoxicity. Febs J 272:4949\u20134959","journal-title":"Febs J"},{"key":"1255_CR25","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1006\/bbrc.1999.1989","volume":"267","author":"S Janciauskiene","year":"2000","unstructured":"Janciauskiene S, Ahren B (2000) Fibrillar islet amyloid polypeptide differentially affects oxidative mechanisms and lipoprotein uptake in correlation with cytotoxicity in two insulin-producing cell lines. Biochem Biophys Res Commun 267:619\u2013625","journal-title":"Biochem Biophys Res Commun"},{"key":"1255_CR26","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1006\/bbrc.1998.9574","volume":"251","author":"S Janciauskiene","year":"1998","unstructured":"Janciauskiene S, Ahren B (1998) Different sensitivity to the cytotoxic action of IAPP fibrils in two insulin-producing cell lines, HIT-T15 and RINm5F cells. Biochem Biophys Res Commun 251:888\u2013893","journal-title":"Biochem Biophys Res Commun"},{"key":"1255_CR27","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1073\/pnas.92.6.1989","volume":"92","author":"D Schubert","year":"1995","unstructured":"Schubert D, Behl C, Lesley R et al (1995) Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci USA 92:1989\u20131993","journal-title":"Proc Natl Acad Sci USA"},{"key":"1255_CR28","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1471-4159.1998.71020506.x","volume":"71","author":"HM Tucker","year":"1998","unstructured":"Tucker HM, Rydel RE, Wright S, Estus S (1998) Human amylin induces \u201capoptotic\u201d pattern of gene expression concomitant with cortical neuronal apoptosis. J Neurochem 71:506\u2013516","journal-title":"J Neurochem"},{"key":"1255_CR29","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2337\/diab.43.12.1457","volume":"43","author":"DA D\u2019Alessio","year":"1994","unstructured":"D\u2019Alessio DA, Verchere CB, Kahn SE et al (1994) Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes 43:1457\u20131461","journal-title":"Diabetes"},{"key":"1255_CR30","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.2337\/diabetes.49.12.2056","volume":"49","author":"S Andrikopoulos","year":"2000","unstructured":"Andrikopoulos S, Verchere CB, Terauchi Y, Kadowaki T, Kahn SE (2000) Beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes. Diabetes 49:2056\u20132062","journal-title":"Diabetes"},{"key":"1255_CR31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0003-9861(02)00397-1","volume":"405","author":"S Zraika","year":"2002","unstructured":"Zraika S, Dunlop M, Proietto J, Andrikopoulos S (2002) The hexosamine biosynthesis pathway regulates insulin secretion via protein glycosylation in mouse islets. Arch Biochem Biophys 405:275\u2013279","journal-title":"Arch Biochem Biophys"},{"key":"1255_CR32","doi-asserted-by":"crossref","first-page":"C1586","DOI":"10.1152\/ajpcell.00208.2007","volume":"293","author":"RL Hull","year":"2007","unstructured":"Hull RL, Zraika S, Udayasankar J et al (2007) Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro. Am J Physiol Cell Physiol 293:C1586\u2013C1593","journal-title":"Am J Physiol Cell Physiol"},{"key":"1255_CR33","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0002-9440(10)63771-6","volume":"164","author":"R Kisilevsky","year":"2004","unstructured":"Kisilevsky R, Szarek WA, Ancsin JB et al (2004) Inhibition of amyloid A amyloidogenesis in vivo and in tissue culture by 4-deoxy analogues of peracetylated 2-acetamido-2-deoxy-alpha- and beta-d-glucose: implications for the treatment of various amyloidoses. Am J Pathol 164:2127\u20132137","journal-title":"Am J Pathol"},{"key":"1255_CR34","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1042\/bj20030422","volume":"374","author":"JF Aitken","year":"2003","unstructured":"Aitken JF, Loomes KM, Konarkowska B, Cooper GJ (2003) Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid. Biochem J 374:779\u2013784","journal-title":"Biochem J"},{"key":"1255_CR35","doi-asserted-by":"crossref","first-page":"12206","DOI":"10.1074\/jbc.M312452200","volume":"279","author":"JD Green","year":"2004","unstructured":"Green JD, Goldsbury C, Kistler J, Cooper GJ, Aebi U (2004) Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation. J Biol Chem 279:12206\u201312212","journal-title":"J Biol Chem"},{"key":"1255_CR36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1074\/jbc.M307907200","volume":"279","author":"X Li","year":"2004","unstructured":"Li X, Chen H, Epstein PN (2004) Metallothionein protects islets from hypoxia and extends islet graft survival by scavenging most kinds of reactive oxygen species. J Biol Chem 279:765\u2013771","journal-title":"J Biol Chem"},{"key":"1255_CR37","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1210\/endo.138.4.5069","volume":"138","author":"L Scaglia","year":"1997","unstructured":"Scaglia L, Cahill CJ, Finegood DT, Bonner-Weir S (1997) Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138:1736\u20131741","journal-title":"Endocrinology"},{"key":"1255_CR38","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.2337\/diabetes.50.11.2514","volume":"50","author":"F Wang","year":"2001","unstructured":"Wang F, Hull RL, Vidal J, Cnop M, Kahn SE (2001) Islet amyloid develops diffusely throughout the pancreas before becoming severe and replacing endocrine cells. Diabetes 50:2514\u20132520","journal-title":"Diabetes"},{"key":"1255_CR39","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2337\/db06-0430","volume":"56","author":"S Zraika","year":"2007","unstructured":"Zraika S, Hull RL, Udayasankar J et al (2007) Identification of the amyloid-degrading enzyme neprilysin in mouse islets and potential role in islet amyloidogenesis. Diabetes 56:304\u2013310","journal-title":"Diabetes"},{"key":"1255_CR40","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2337\/diabetes.54.5.1437","volume":"54","author":"H Chen","year":"2005","unstructured":"Chen H, Li X, Epstein PN (2005) MnSOD and catalase transgenes demonstrate that protection of islets from oxidative stress does not alter cytokine toxicity. Diabetes 54:1437\u20131446","journal-title":"Diabetes"},{"key":"1255_CR41","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2337\/diabetes.53.4.989","volume":"53","author":"C Tikellis","year":"2004","unstructured":"Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME (2004) Improved islet morphology after blockade of the renin\u2013angiotensin system in the ZDF rat. Diabetes 53:989\u2013997","journal-title":"Diabetes"},{"key":"1255_CR42","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1089\/ars.2007.1763","volume":"9","author":"K Leuner","year":"2007","unstructured":"Leuner K, Hauptmann S, Abdel-Kader R et al (2007) Mitochondrial dysfunction: the first domino in brain aging and Alzheimer\u2019s disease. Antioxid Redox Signal 9:1659\u20131675","journal-title":"Antioxid Redox Signal"},{"key":"1255_CR43","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.2337\/diabetes.48.12.2398","volume":"48","author":"H Kaneto","year":"1999","unstructured":"Kaneto H, Kajimoto Y, Miyagawa J et al (1999) Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 48:2398\u20132406","journal-title":"Diabetes"},{"key":"1255_CR44","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1073\/pnas.96.19.10857","volume":"96","author":"Y Tanaka","year":"1999","unstructured":"Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP (1999) Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci USA 96:10857\u201310862","journal-title":"Proc Natl Acad Sci USA"},{"key":"1255_CR45","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s00125-006-0212-9","volume":"49","author":"S Zraika","year":"2006","unstructured":"Zraika S, Aston-Mourney K, Laybutt DR et al (2006) The influence of genetic background on the induction of oxidative stress and impaired insulin secretion in mouse islets. Diabetologia 49:1254\u20131263","journal-title":"Diabetologia"},{"key":"1255_CR46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1677\/jme.1.01720","volume":"35","author":"S Kooptiwut","year":"2005","unstructured":"Kooptiwut S, Kebede M, Zraika S et al (2005) High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction. J Mol Endocrinol 35:39\u201348","journal-title":"J Mol Endocrinol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-008-1255-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-008-1255-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-008-1255-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:47:09Z","timestamp":1558612029000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-008-1255-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,16]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["1255"],"URL":"https:\/\/doi.org\/10.1007\/s00125-008-1255-x","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,16]]}}}